Detailed information for compound 1780494
Basic information
Technical information
- Name: Unnamed compound
- MW: 404.465 | Formula: C22H24N6O2
-
H donors: 0
H acceptors: 4
LogP: 2.55
Rotable bonds: 4
Rule of 5 violations (Lipinski): 1 - SMILES: CC[C@H]1N([C@H]2COCC2)c2nc(ncc2N(C1=O)C)n1ccnc1c1ccccc1
- InChi: 1S/C22H24N6O2/c1-3-17-21(29)26(2)18-13-24-22(25-20(18)28(17)16-9-12-30-14-16)27-11-10-23-19(27)15-7-5-4-6-8-15/h4-8,10-11,13,16-17H,3,9,12,14H2,1-2H3/t16-,17-/m1/s1
- InChiKey: UMJFDLYATACWKW-IAGOWNOFSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | References |
| Homo sapiens | polo-like kinase 2 | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 1 |
| Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 0.5 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Mycobacterium ulcerans | thymidylate synthase | 0.046 | 1 | 0.5 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Loa Loa (eye worm) | thymidylate synthase | 0.046 | 1 | 1 |
| Onchocerca volvulus | 0.046 | 1 | 1 | |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Giardia lamblia | Kinase, PLK | 0.0228 | 0.3261 | 0.5 |
| Echinococcus multilocularis | thymidylate synthase | 0.046 | 1 | 1 |
| Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0228 | 0.3261 | 0.0386 |
| Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.046 | 1 | 0.5 |
| Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 1 |
| Trypanosoma cruzi | polo-like protein kinase, putative | 0.0228 | 0.3261 | 0.0386 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Echinococcus granulosus | thymidylate synthase | 0.046 | 1 | 1 |
| Trypanosoma cruzi | polo-like protein kinase, putative | 0.0228 | 0.3261 | 0.0386 |
| Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.046 | 1 | 0.5 |
| Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.046 | 1 | 1 |
| Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0228 | 0.3261 | 0.5 |
| Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 1 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
| Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 0.5 |
| Schistosoma mansoni | serine/threonine protein kinase | 0.0228 | 0.3261 | 0.3261 |
| Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.046 | 1 | 1 |
| Trichomonas vaginalis | CAMK family protein kinase | 0.0228 | 0.3261 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 0.021 uM | Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay | ChEMBL. | 23522834 |
| IC50 (binding) | = 0.48 uM | Inhibition of GST-tagged Plk1 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay | ChEMBL. | 23522834 |
| Stabilty (ADMET) | = 27 % | Metabolic stability in mouse liver microsomes assessed as compound remaining at 1 uM after 30 mins | ChEMBL. | 23522834 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL2401972
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.